bg
N

Nuvalent (NUVL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Nuvalent (NUVL)

Nuvalent, Inc. is a preclinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. The Company is advancing a pipeline of product candidates with parallel programs in cancers driven by genomic a... Read more

  • USD62.95
  • USD64.71
  • USD61.80
  • USD89.39
  • -19.30%
  • --
  • 1.25M
  • 609.27k
  • 3.8B
  • 32.06
  • 100.80%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.